Mesothelioma Diagnosis: A Comprehensive Guideline-based Approach

1. Berzenji L, Van Schil PE, Carp L. The eighth TNM classification for malignant pleural mesothelioma. Transl Lung Cancer Res. 2018;7(5). doi:10.21037/tlcr.2018.07.05 Berzenji L Van Schil PE Carp L. The eighth TNM classification for malignant pleural mesothelioma . Transl Lung Cancer Res . 2018 ; 7 ( 5 ). doi: 10.21037/tlcr.2018.07.05 Open DOISearch in Google Scholar

2. Woolhouse I, Bishop L, Darlison L, et al. BTS guideline for the investigation and management of malignant pleural mesothelioma. BMJ Open Respir Res. 2018;5(1). doi:10.1136/bmjresp-2017-000266 Woolhouse I Bishop L Darlison L BTS guideline for the investigation and management of malignant pleural mesothelioma . BMJ Open Respir Res . 2018 ; 5 ( 1 ). doi: 10.1136/bmjresp-2017-000266 Open DOISearch in Google Scholar

3. Popat S, Baas P, Faivre-Finn C, et al. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2022;33(2). doi:10.1016/j.annonc.2021.11.005 Popat S Baas P Faivre-Finn C Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up . Annals of Oncology . 2022 ; 33 ( 2 ). doi: 10.1016/j.annonc.2021.11.005 Open DOISearch in Google Scholar

4. Scherpereel A, Scherpereel A, Opitz I, et al. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma. European Respiratory Journal. 2020;55(6). doi:10.1183/13993003.00953-2019 Scherpereel A Scherpereel A Opitz I ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma . European Respiratory Journal . 2020 ; 55 ( 6 ). doi: 10.1183/13993003.00953-2019 Open DOISearch in Google Scholar

5. Barbieri PG, Somigliana A, Girelli R, Lombardi S, Sarnico M, Silvestri S. [Pleural mesothelioma in a school teacher: asbestos exposure due to DAS paste]. Med Lav. 2016;107(2). Barbieri PG Somigliana A Girelli R Lombardi S Sarnico M Silvestri S. [Pleural mesothelioma in a school teacher: asbestos exposure due to DAS paste] . Med Lav . 2016 ; 107 ( 2 ). Search in Google Scholar

6. Messina G, Bove M, Natale G, et al. Diagnosis of malignant pleural disease: Ultrasound as “a detective probe.” Thorac Cancer. 2023;14(3). doi:10.1111/1759-7714.14735 Messina G Bove M Natale G Diagnosis of malignant pleural disease: Ultrasound as “a detective probe .” Thorac Cancer . 2023 ; 14 ( 3 ). doi: 10.1111/1759-7714.14735 Open DOISearch in Google Scholar

7. Sinha S, Swift AJ, Kamil MA, et al. The role of imaging in malignant pleural mesothelioma: an update after the 2018 BTS guidelines. Clin Radiol. 2020;75(6). doi:10.1016/j.crad.2019.12.001 Sinha S Swift AJ Kamil MA The role of imaging in malignant pleural mesothelioma: an update after the 2018 BTS guidelines . Clin Radiol . 2020 ; 75 ( 6 ). doi: 10.1016/j.crad.2019.12.001 Open DOISearch in Google Scholar

8. Shiroshita A, Kurosaki M, Takeshita M, Kataoka Y. Medical thoracoscopy, computed tomography-guided biopsy, and ultrasound-guided biopsy for malignant pleural mesothelioma: A systematic review. Anticancer Res. 2021;41(5). doi:10.21873/ANTICANRES.14998 Shiroshita A Kurosaki M Takeshita M Kataoka Y. Medical thoracoscopy, computed tomography-guided biopsy, and ultrasound-guided biopsy for malignant pleural mesothelioma: A systematic review . Anticancer Res . 2021 ; 41 ( 5 ). doi: 10.21873/ANTICANRES.14998 Open DOISearch in Google Scholar

9. Friedberg JS, Culligan MJ, Tsao AS, et al. A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute–International Association for the Study of Lung Cancer–Mesothelioma Applied Research Foundation Taskforce. Journal of Thoracic Oncology. 2019;14(8). doi:10.1016/j.jtho.2019.04.029 Friedberg JS Culligan MJ Tsao AS A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute–International Association for the Study of Lung Cancer–Mesothelioma Applied Research Foundation Taskforce . Journal of Thoracic Oncology . 2019 ; 14 ( 8 ). doi: 10.1016/j.jtho.2019.04.029 Open DOISearch in Google Scholar

10. Michael CW, Bedrossian CCWM, Sadri N, Klebe S. The cytological features of effusions with mesothelioma in situ: A report of 9 cases. Diagn Cytopathol. Published online 2023. doi:10.1002/dc.25129 Michael CW Bedrossian CCWM Sadri N Klebe S. The cytological features of effusions with mesothelioma in situ: A report of 9 cases . Diagn Cytopathol . Published online 2023. doi: 10.1002/dc.25129 Open DOISearch in Google Scholar

11. Courtiol P, Maussion C, Moarii M, et al. Deep learning-based classification of mesothelioma improves prediction of patient outcome. Nat Med. 2019;25(10). doi:10.1038/s41591-019- 0583-3 Courtiol P Maussion C Moarii M Deep learning-based classification of mesothelioma improves prediction of patient outcome . Nat Med . 2019 ; 25 ( 10 ). doi: 10.1038/s41591-019-0583-3 Open DOISearch in Google Scholar

12. Borgeaud M, Kim F, Friedlaender A, Lococo F, Addeo A, Minervini F. The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma. J Clin Med. 2023;12(5). doi:10.3390/jcm12051757 Borgeaud M Kim F Friedlaender A Lococo F Addeo A Minervini F. The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma . J Clin Med . 2023 ; 12 ( 5 ). doi: 10.3390/jcm12051757 Open DOISearch in Google Scholar